The Sequence Radar #880: Last Week in AI: A $60B Cursor Deal, Google's Brain Drain, and Midjourney's Body Scanner

Key Takeaways

• SpaceX to buy Cursor for $60 B, signaling AI tooling as core infrastructure
• Google loses Noam Shazeer and John Jumper to rivals, highlighting talent scarcity
• Midjourney launches ultrasonic CT scanner, moving generative AI into medical imaging
• AI startups raise over $2 B collectively, underscoring continued capital appetite
• Alibaba unveils new embodied intelligence models, expanding AI into robotics

Pulse Analysis

SpaceX's $60 billion acquisition of Cursor underscores a pivotal shift: AI development tools are being treated as essential infrastructure on par with rockets and launch pads. By integrating an advanced code‑completion engine into its xAI division, SpaceX aims to accelerate internal software cycles and lock in a proprietary AI stack, a strategy that could pressure other industrial giants to pursue similar annexations rather than simple partnerships. This deal also signals that valuation benchmarks for AI tooling have vaulted into the billions, reshaping M&A expectations across the sector.

The talent exodus from Google highlights the growing gravity of individual researchers in the AI ecosystem. Noam Shazeer, a key architect of the transformer model, and John Jumper, the mind behind AlphaFold, both departed within days, moving to OpenAI and Anthropic respectively. Their exits reveal that even multi‑billion‑dollar retention packages cannot guarantee loyalty when the pull of research freedom and influence intensifies. Companies now compete not just on compute power but on the ability to offer compelling scientific autonomy, making talent the most valuable accelerator in the race for AI supremacy.

Midjourney's foray into ultrasonic CT imaging illustrates how generative‑AI firms are leveraging their expertise in visual synthesis to break into hardware‑intensive domains. While the prototype currently scans a dozen subjects over twenty minutes, the ambition to achieve full‑body scans in sixty seconds points to a future where AI‑enhanced imaging could lower costs and expand access to diagnostic tools. Coupled with Alibaba's rollout of embodied‑intelligence models for robotics, the industry narrative is expanding beyond software, blending AI with physical devices and medical applications—a convergence that promises new revenue streams and regulatory challenges alike.